Emerging therapeutic targets in non-small cell lung cancer

Grace K. Dy, Alex Adjei

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Over the last decade, systemic cancer therapies have evolved to exploit the growing knowledge of molecular aberrations involved in the development and progression of lung cancer. This review highlights the biological targets relevant in the treatment of non-small cell lung cancer.

Original languageEnglish (US)
Pages (from-to)218-223
Number of pages6
JournalProceedings of the American Thoracic Society
Volume6
Issue number2
DOIs
StatePublished - Apr 15 2009
Externally publishedYes

Fingerprint

Non-Small Cell Lung Carcinoma
Lung Neoplasms
Neoplasms
Therapeutics

Keywords

  • Angiogenesis
  • Epidermal growth factor receptor
  • Non-small cell lung cancer
  • Vaccine

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Emerging therapeutic targets in non-small cell lung cancer. / Dy, Grace K.; Adjei, Alex.

In: Proceedings of the American Thoracic Society, Vol. 6, No. 2, 15.04.2009, p. 218-223.

Research output: Contribution to journalArticle

@article{62bd8207981947b4959fdbf88af1f7c9,
title = "Emerging therapeutic targets in non-small cell lung cancer",
abstract = "Over the last decade, systemic cancer therapies have evolved to exploit the growing knowledge of molecular aberrations involved in the development and progression of lung cancer. This review highlights the biological targets relevant in the treatment of non-small cell lung cancer.",
keywords = "Angiogenesis, Epidermal growth factor receptor, Non-small cell lung cancer, Vaccine",
author = "Dy, {Grace K.} and Alex Adjei",
year = "2009",
month = "4",
day = "15",
doi = "10.1513/pats.200808-099LC",
language = "English (US)",
volume = "6",
pages = "218--223",
journal = "Annals of the American Thoracic Society",
issn = "2325-6621",
publisher = "American Thoracic Society",
number = "2",

}

TY - JOUR

T1 - Emerging therapeutic targets in non-small cell lung cancer

AU - Dy, Grace K.

AU - Adjei, Alex

PY - 2009/4/15

Y1 - 2009/4/15

N2 - Over the last decade, systemic cancer therapies have evolved to exploit the growing knowledge of molecular aberrations involved in the development and progression of lung cancer. This review highlights the biological targets relevant in the treatment of non-small cell lung cancer.

AB - Over the last decade, systemic cancer therapies have evolved to exploit the growing knowledge of molecular aberrations involved in the development and progression of lung cancer. This review highlights the biological targets relevant in the treatment of non-small cell lung cancer.

KW - Angiogenesis

KW - Epidermal growth factor receptor

KW - Non-small cell lung cancer

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=65349149344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65349149344&partnerID=8YFLogxK

U2 - 10.1513/pats.200808-099LC

DO - 10.1513/pats.200808-099LC

M3 - Article

C2 - 19349491

AN - SCOPUS:65349149344

VL - 6

SP - 218

EP - 223

JO - Annals of the American Thoracic Society

JF - Annals of the American Thoracic Society

SN - 2325-6621

IS - 2

ER -